Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • EliG
    Junior Member
    • Aug 2009
    • 3

    #1

    Technical artefacts create supposed fake mosaics

    Dear community,

    In recent months, we have observed an increase in incidents in which we find de novo variants in the index in a trio (exome and genome) analysis and the variant is present in 1-2% of the reads in the parents.
    Due to the accumulation, we rather assume a technical artefact of Illumina sequencing (NovaSeq6000) where we cannot explain where it comes from.
    Do you also see something like this in your data or do you have an idea where it could come from?

    For the following reasons we assume a technical artefact and not a real parental mosaic:

    1. exclusion of cotamination of the parental samples by the child's DNA, because the samples were processed in different batches at different times.
    2. we see this in both exomes and genomes (PCR free) and conclude that it is not due to the lib prep.
    3. there are cases where both parents carry the same supposedly heterozygous de novo variant (in child) in the mosaic. This is extremely unlikely.

    Thank you very much for your input
    Best regards
    EliG

Latest Articles

Collapse

  • SEQadmin2
    16S/ITS Profiling vs. Shotgun Metagenomics: What Changes in Your Workflow?
    by SEQadmin2




    NGS has revolutionized clinical microbiology by offering new ways to identify and surveil pathogens without prior knowledge of the target. One popular approach is 16S rRNA and ITS amplicon sequencing, which targets specific microbial markers. But studies are increasingly incorporating shotgun metagenomics, a technique that sequences all DNA from a sample without targeting specific microbial markers. This approach allows more detailed taxonomic classification, detection...
    Today, 06:46 AM
  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-28-2026, 09:57 AM
0 responses
22 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-28-2026, 09:51 AM
0 responses
14 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
67 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
47 views
0 reactions
Last Post SEQadmin2  
Working...